COVID-19 Management with Corticosteroids

Introduction to Corticosteroid Use

The American College of Physicians and other medical societies recommend dexamethasone for COVID-19 patients requiring oxygen support or mechanical ventilation, based on robust evidence showing mortality reduction 1, 2, 3

For patients with moderate to severe COVID-19 requiring supplemental oxygen, the recommended dose of dexamethasone is 6 mg once daily (oral or intravenous) for up to 10 days, as suggested by the European Respiratory Society 1, 5, 4
Dexamethasone has been shown to reduce 28-day mortality by 35% in patients on invasive mechanical ventilation and by 20% in patients requiring supplemental oxygen therapy, according to the European Respiratory Journal 5, 4

The strongest evidence supporting corticosteroid use in COVID-19 comes from the RECOVERY trial, which specifically evaluated dexamethasone 6 mg daily, providing high-quality data on mortality benefit 5, 4
Current guidelines from multiple organizations, including the American Thoracic Society, specifically recommend dexamethasone based on this high-quality evidence 1, 2, 6, 4

The recommended dose of dexamethasone is 6 mg once daily (oral or intravenous) for up to 10 days, as suggested by the Infectious Diseases Society of America 5, 4
In patients requiring oxygen therapy or mechanical ventilation, consider combining dexamethasone with remdesivir, as recommended by the National Institutes of Health 1, 2, 3

In patients with hematological malignancies and COVID-19, dexamethasone is recommended for moderate, severe, and critical disease, according to the American Society of Hematology 1, 2